Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Corticosteroid disadvantages [no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clinical corticosteroid therapy |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estrogens |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Menstrual symptons - combined preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Male sex hormones and antagonists |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyproterone acetate [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Endometriosis drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Other drugs used in diabetes |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Other endocrine drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Topical hormones for vaginal+vulval conditions |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Combined oral contraceptive - ethinylestradiol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone acetate [combined oral contraceptive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone [combined oral contraceptive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estrogens in malignant disease |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Progestogens in malignant disease |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gestronol hexanoate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hormone receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyproterone acet [malignancy] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyproterone acetate [acne] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nilutamide 150 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely thiamazole 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thiamazole 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely thiamazole 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Flutamide 125 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Finasteride 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tamoxifen citrate 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Toremifene citrate 60mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fulvestrant 50mg/mL injection solution 5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fulvestrant 50mg/mL injection solution 2.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dutasteride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dutasteride 500 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing drospirenone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pegvisomant 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norgestrel 75 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Toremifene (as toremifene citrate) 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fulvestrant-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing thiamazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nilutamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hormone antagonist |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenaline |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Synthetic hormone agent |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hormone precursor |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tiratricol (substance) |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Exophthalmos producing substance |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Adrenal hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anterior pituitary hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary hormone |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Selective progesterone receptor modulator |
Is a |
False |
hormones et leurs métabolites et précurseurs |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|